Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Patients with overactive bladder (OAB) who have failed an oral therapy have a number of treatment options including onabotulinumtoxinA (onabotA) injection, percutaneous tibial nerve stimulation (PTNS), or implantable sacral neurostimulation (SNS) device. This analysis estimates the cost-effectiveness of onabotA 100U compared to PTNS and SNS from the US payer perspective.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
